Snapshot

DOI:

An expert review on managing cardiovascular masses using transcatheter vacuum-assisted aspiration; revascularisation vs medical therapy in 3-vessel disease; CT-μFR; follow-up after mitral transcatheter edge-to-edge repair; design of the DAPT-SHOCK-AMI trial; and more

From the aspiration of cardiovascular masses to new techniques for evaluating coronary lesions, or anatomical changes after mitral valve edge-to edge repair, a wide variety of topics are touched on in this issue – but what about that gorilla hiding in your cath lab? Do you know what that could be?

Transcatheter vacuum-assisted aspiration has become an alternative to surgery for certain high-risk patients with intracardiac and intravascular masses of various aetiologies, often seen as thrombi, tumours, or vegetations. In an expert review, Laura Besola, Andrea Colli and colleagues go over the current clinical evidence, indications and the different uses of vacuum-assisted aspiration in the treatment.

In a post hoc analysis of the ISCHEMIA trial, Sripal Bangalore, Judith S. Hochman and colleagues evaluate the outcomes of revascularisation versus medical therapy in patients with three-vessel coronary artery disease. Revascularisation, including both percutaneous coronary intervention and coronary artery bypass grafting, was associated with lower rates of cardiovascular death and myocardial infarction at four years, as well as an improved quality of life.

Tingwen Weng, Shengxian Tu and colleagues investigate the diagnostic performance of the Murray law-based quantitative flow ratio (CT-μFR), which is a novel coronary computed tomography angiography-derived method for quickly computing fractional flow reserve and identifying haemodynamically significant coronary stenoses and lesions.

Using transoesophageal echocardiography (TOE), Joanna Bartkowiak, Fabien Praz and colleagues evaluate anatomical changes and structural complications after mitral transcatheter edge-to-edge repair, investigating their association with clinical outcomes at two years.

Describing the upcoming DAPT-SHOCK-AMI trial, Zuzana Motovska, Deepak L. Bhatt and colleagues discuss the rationale and design of this study, which will randomise more than 500 patients to evaluate the benefits of cangrelor vs crushed ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock.

Volume 20 Number 20
Oct 21, 2024
Volume 20 Number 20
View full issue

Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
154.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
47.4

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
43.65

Clinical research

10.4244/EIJ-D-23-00590 Dec 4, 2023
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Nakase M et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
34.75

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved